enVVeno Medical Corp - Common Stock, $0.00001 par value (NVNO)
CUSIP: 29415J106
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, $0.00001 par value
- Shares outstanding
- 20,505,656
- Total 13F shares
- 5,079,935
- Share change
- +1,439,554
- Total reported value
- $20,269,051
- Put/Call ratio
- 0%
- Price per share
- $3.99
- Number of holders
- 36
- Value change
- +$6,075,451
- Number of buys
- 19
- Number of sells
- 11
Quarterly Holders Quick Answers
What is CUSIP 29415J106?
CUSIP 29415J106 identifies NVNO - enVVeno Medical Corp - Common Stock, $0.00001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 29415J106:
Top shareholders of NVNO - enVVeno Medical Corp - Common Stock, $0.00001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
4.2%
|
859,261
|
$2,259,856 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.9%
|
600,906
|
$1,580,383 | — | 31 Mar 2025 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
2.9%
|
594,661
|
$1,563,958 | — | 31 Mar 2025 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
1.4%
|
296,031
|
$778,562 | — | 31 Mar 2025 | |
| Westside Investment Management, Inc. |
13F
|
Company |
1.3%
|
259,050
|
$681,309 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.96%
|
197,298
|
$518,965 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.95%
|
194,213
|
$510,780 | — | 31 Mar 2025 | |
| Altium Capital Management LLC |
13F
|
Company |
0.6%
|
123,256
|
$324,163 | — | 31 Mar 2025 | |
| Dauntless Investment Group, LLC |
13F
|
Company |
0.35%
|
70,848
|
$186,330 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.32%
|
65,964
|
$173,485 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.3%
|
60,608
|
$159,399 | — | 31 Mar 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.2%
|
41,438
|
$108,982 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.2%
|
40,800
|
$107,304 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.2%
|
40,129
|
$105,539 | — | 31 Mar 2025 | |
| Fermata Advisors, LLC |
13F
|
Company |
0.19%
|
39,399
|
$103,619 | — | 31 Mar 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.15%
|
30,437
|
$80,049 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.13%
|
26,421
|
$69,487 | — | 31 Mar 2025 | |
| Laird Norton Wetherby Trust Company, LLC |
13F
|
Company |
0.12%
|
25,000
|
$65,750 | — | 31 Mar 2025 | |
| HOHIMER WEALTH MANAGEMENT, LLC |
13F
|
Company |
0.1%
|
20,000
|
$52,600 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.08%
|
16,119
|
$42,393 | — | 31 Mar 2025 | |
| Tamar Securities, LLC |
13F
|
Company |
0.07%
|
13,990
|
$36,794 | — | 31 Mar 2025 | |
| Sanctuary Advisors, LLC |
13F
|
Company |
0.06%
|
12,000
|
$31,560 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.05%
|
10,771
|
$28,327 | — | 31 Mar 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.04%
|
8,284
|
$21,787 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
2,002
|
$5,265 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
1,604
|
$4,218 | — | 31 Mar 2025 | |
| CIBC Private Wealth Group LLC |
13F
|
Company |
0%
|
860
|
$1,823 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
625
|
$1,643 | — | 31 Mar 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
250
|
$657 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
150
|
$394 | — | 31 Mar 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
6
|
$16 | — | 31 Mar 2025 | |
| Jennifer Bright |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
350,000
|
— | — | 19 May 2025 | |
| Craig Glynn |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
75,000
|
— | — | 05 Dec 2023 |
Institutional Holders of enVVeno Medical Corp - Common Stock, $0.00001 par value (NVNO) as of Q2 2025
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.